Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Bosentan on the Pharmacokinetics of Nintedanib in Healthy Male Subjects

NCT02667704 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT02667704
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02667704 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Bosentan on the Pharmacokinetics of Nintedanib in Healthy Male Subjects
Lead sponsor
Boehringer Ingelheim
Phase
Phase 1
Overall status
Completed
Start date
February 29, 2016
Completion date
March 31, 2016
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy